Home > News > Monday's Health Winners & Losers
July 2nd, 2007
Monday's Health Winners & Losers
Small-cap bio-nanotech company pSivida (PSDV - Cramer's Take - Stockpickr) took off in the opposite direction after announcing that it entered an agreement for a direct offering to sell its Nasdaq-traded American Depositary Shares and warrants to purchase ADSs, including $6.5 million, to Pfizer (PFE - Cramer's Take - Stockpickr - Rating).
It estimates the net proceeds from the offering will be $16.3 million after the placement agent fees and estimated offering expenses. Shares of pSivida were down 32 cents, or 21%, to $1.20.
Nanometrics Announces Upcoming Investor Events November 19th, 2014
Eight19 secures £1m funding: Investment to develop production technology, and expand commercial activities for organic photovoltaics November 19th, 2014
Arrowhead to Present at Upcoming Conferences November 15th, 2014
Harris & Harris Group Reports Financial Statements as of September 30, 2014 November 11th, 2014
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
University of Minnesota engineers make sound loud enough to bend light on a computer chip: Device could improve wireless communications systems November 28th, 2014
Study details laser pulse effects on behavior of electrons November 28th, 2014
Single-atom gold catalysts may offer path to low-cost production of fuel and chemicals November 28th, 2014
Production of Anticancer Drug from Nanofibers in Iran November 28th, 2014